NEW YORK, April 6 The next phase of health reform in the United States will reflect a concerted effort to keep people well, out of the hospital and more actively engaged in managing their own health, according to PricewaterhouseCoopers LLP (PwC). Embedded in the U.S. Health Reform package are lesser known provisions that increase emphasis on prevention, positive health outcomes, better coordination of care and comparative effectiveness research that includes personalized medicine, paving the way for a new era of individualized care in a more patient-focused health system.
Pilot programs for the creation of accountable care organizations and collaborative care networks, new reimbursement models and increased funding for community and primary care services are keys to improving outcomes and reducing health costs. These seeds, planted in the new law, mark a turning point for healthcare delivery in the U.S. and support the conclusions of a year-long study by PricewaterhouseCoopers' Health Research as detailed in a report published today entitled HealthCast: The customization of diagnosis, care and cure.
PricewaterhouseCoopers' research identified an emerging phenomenon, not only in the U.S. but in every major health system around the world: In response to the global recession and pressure to reduce rising healthcare costs associated with chronic diseases, government and health leaders see the potential for individuals to take greater ownership of their health and the need for fundamental structural changes in the health system to help them do so.
PwC expects that over the next five years, the trend will lead to significant health industry business model changes, more regulatory reforms focused on efficiency and effectiveness, greater investments in prevention and a growing role for information technology to enable information-sharing and provide interactive, customized care in a virtual world.
Nearly 600 government and health leaders in 20 countries, including 50 health leaders in the U.S. were surveyed by PricewaterhouseCoopers' Health Research Institute. Findings include:
"Through incentives baked into our health system, many health organizations have been too siloed in their thinking. They've focused on their silo rather than the whole continuum of care and patient engagement. If patients are not engaged, it is impossible to adequately manage care, consumption and spending." said Kelly A. Barnes, US Health Industries Leader, PricewaterhouseCoopers. "The overarching challenge for our health system will be to shift the internal focus from the siloed bureaucratic healthcare infrastructure that exists today to one that puts patients at the center of care and engages them to take charge of their health over their entire lifetime."
Mass Customization of Care Driven by Digitization and Personalized Medicine
PricewaterhouseCoopers' analysis found that healthcare is playing catch-up to adopt innovations and trends in consumerism from other service industries such as automotive, retail and entertainment. It concludes that healthcare needs to become more adept at customizing health solutions to consumer-centric attributes and segmenting consumers beyond health status or disease group, looking at economic status, personal preferences and cultural barriers to change.
According to the report, mass customization will be enabled by technology and the convergence of multiple devices such as smart phones, EMR databases, home health monitoring, telehealth, as well as wireless communication, social media and other Internet innovations. But it is personalized medicine and greater understanding of the human genome that PricewaterhouseCoopers says is at the heart of customized diagnosis, care and cure.
"We have a better understanding that chronic diseases are influenced by a combination of genetic factors, individual behavior and the environment, which are not within the control of today's medical delivery system," said David Levy, MD, global health leader at PricewaterhouseCoopers. "The practice of medicine will undergo transformational change when scientists, clinicians and individuals are armed with knowledge about genetic variations and when patients and doctors can use this information together to guide lifelong behavior and treatment decisions."
Ninety percent of U.S. health leaders and 84 percent of global health leaders surveyed by PricewaterhouseCoopers believe that the merging of information technology and healthcare is a key factor for change. Fifty-eight percent of U.S. health leaders and 45 percent of global health leaders said they expect personalized medicine to be an important and growing development that will change healthcare delivery.
Strategies for Changing Behavior
When PwC surveyed health leaders about the most effective strategy to engage individuals in their own health, the top answers revolved around education and communication; the top three were health education, greater awareness and increased patient responsibility. The fourth was better communication, but the ordering of these strategies shows that health leaders recognize there's a lot of education and relationship building needed to support individuals.
Also recognized is the need to change incentives in a way that strengthens partnerships between physicians, their patients and employers, and which link their success to mutual goals around health and wellness.
A Toolkit for Customizing the Consumer Experience
In its report, PwC outlines five areas where health systems can customize care and better engage individuals in managing their health.
HealthCast: The customization of diagnosis, care and cure builds on three previously published reports by PricewaterhouseCoopers' Health Research Institute that accurately forecasted as early as 1999 the initial influence of consumerism, genomics and the Internet on healthcare. The entire healthcare series of reports can be found at www.pwc.com/healthcast.
As part of its research, PricewaterhouseCoopers' Health Research Institute commissioned a survey of 590 leaders of health plans, providers, government, employers, physician groups and pharmaceutical/life science firms in 20 countries and conducted more than 200 in-depth interviews in 25 countries with thought leaders and executives representing government, hospitals, pharmaceutical companies, insurance companies, clinicians, academics and the business community.
About PricewaterhouseCoopers' Health Research Institute (HRI)
PricewaterhouseCoopers' Health Research Institute (www.pwc.com/hri) is an unparalleled resource for health industry expertise. By providing cutting-edge intelligence, perspective and analysis on issues impacting the health industry, HRI assists executive decision-makers and stakeholders worldwide in navigating their most pressing business challenges. PricewaterhouseCoopers is one of the only firms with a dedicated global healthcare research unit, capitalizing on fact-based research and collaborative exchange among our network of professionals with day-to-day experience in the health industries.
About PricewaterhouseCoopers' Health Industries Group
PricewaterhouseCoopers' Health Industries Group (www.pwc.com/healthindustries) is a leading advisor to public and private organizations across the health industry, including payers, providers, academic institutions, health sciences, biotech/medical devices, pharmaceutical companies, employers and new non-traditional market participants in the dynamic healthcare space. PricewaterhouseCoopers has a network of more than 4,000 professionals worldwide and 1,200 professionals in the U.S. dedicated to the health industries.
PricewaterhouseCoopers' Health Industries' clients include 40 of the top 100 hospitals in the U.S. and 16 of the 18 best hospitals as ranked by US News & World Report; all 20 of the world's major pharmaceutical companies; all of the top 20 commercial payers in the U.S.; municipal, state and federal government agencies and many of the world's preeminent medical foundations and associations. Follow PwC Health Industries at http://twitter.com/PwCHealth.
PricewaterhouseCoopers (www.pwc.com) provides industry-focused assurance, tax and advisory services to build public trust and enhance value for its clients and their stakeholders. More than 163,000 people in 151 countries across our network share their thinking, experience and solutions to develop fresh perspectives and practical advice.
"PricewaterhouseCoopers" refers to PricewaterhouseCoopers LLP or, as the context requires, the PricewaterhouseCoopers global network or other member firms of the network, each of which is a separate and independent legal entity.
Đ 2010 PricewaterhouseCoopers LLP. All rights reserved
-- The consensus was that individuals have the greatest influence on their own health status, but that physicians have the greatest external influence on changing patient behavior. -- Ninety-seven percent agreed that patients should have some responsibility for managing their chronic conditions such as obesity, asthma, diabetes and heart disease. Of those, 76 percent of U.S. health leaders and 57 percent of global leaders think patients should have a "great deal" of responsibility in this. -- Eighty-two percent of U.S. health leaders and nearly three-quarters of global health leaders (74 percent) believe that unhealthy behavior will become increasingly unacceptable in their country. -- Lack of willpower was cited as the biggest barrier keeping individuals from managing their own health.